Aptevo Therapeutics Inc. Operating Lease Liability
Aptevo Therapeutics Inc. (APVO) had Operating Lease Liability of $4.63 million as of 2025-12-31, per its 10-K filed 2026-03-26.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2026-03-26
- 2025-12-31: Operating Lease, Liability $4.63M.
- 2024-12-31: Operating Lease, Liability $5.40M.
- 2023-12-31: Operating Lease, Liability $6.08M.
- 2022-12-31: Operating Lease, Liability $6.46M.
| Period end | Operating Lease, Liability | Operating Lease, Liability as first filed |
|---|---|---|
| 2025-12-31 | $4.63M 10-K · filed 2026-03-26 | |
| 2024-12-31 | $5.40M 10-K · filed 2025-02-14 | |
| 2023-12-31 | $6.08M 10-K · filed 2024-03-05 | |
| 2022-12-31 | $6.46M 10-K · filed 2023-03-30 | |
| 2022-05-26 | $4.40M 10-Q · filed 2023-11-14 | |
| 2020-12-31 | $2.36M 10-K · filed 2022-03-24 | $3.33M 10-K · filed 2021-03-31 |
| 2019-12-31 | $4.25M 10-K · filed 2020-03-25 | |
| 2019-09-30 | $4.51M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $4.82M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $5.08M 10-Q · filed 2019-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B |